ARWR - Arrowhead Pharmaceuticals GAAP EPS of -$1.02 misses by $0.80
2024-05-09 16:01:55 ET
More on Arrowhead Pharmaceuticals
- Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade)
- Arrowhead Pharmaceuticals Q2 2024 Earnings Preview
- Arrowhead Pharmaceuticals secures $50M milestone from Royalty Pharma
- Seeking Alpha’s Quant Rating on Arrowhead Pharmaceuticals
- Historical earnings data for Arrowhead Pharmaceuticals